Guilherme Nader Marta: Evergreen study led by Diogo Martins Branco

Guilherme Nader Marta, Oncology Fellow at Jules Bordet Institute, shared on X:

“EVERGREEN study led by Diogo Martins Branco.

A quasi-experimental analysis of >200 pts, showed that Everolimus+ET increased PFS (aHR 0.68, CI 0.47-0.99) vs ET alone after progression on CDK4/6i

EVE had higher efficacy when combined with AI, increased BMI, IDC, and longer prior CDK4/6 Treatment.”

Source: Guilherme Nader Marta/X